What is Incision?
Incision operates at the intersection of MedTech and professional development, providing a comprehensive suite of tools designed for the modern surgical environment. Their flagship offerings, Incision Assist and Incision Academy, serve as critical infrastructure for perioperative teams, offering accredited training and real-time procedural guidance. By digitizing the surgical learning curve, the company addresses the persistent need for standardized, accessible, and high-quality educational resources in hospitals and surgical centers worldwide. Their market position is defined by a decade of operational expertise, enabling them to bridge the gap between traditional surgical training and the demands of contemporary, technology-driven healthcare delivery.
How much funding has Incision raised?
Incision has raised a total of $7M across 1 funding round:
Series B
$7M
Series B (2023): $7M with participation from Dennendonck
Key Investors in Incision
Dennendonck
Dennendonck Investments is a specialized family office focused on providing private capital to small and medium-sized healthcare companies, with a particular emphasis on MedTech and E-health innovation.
What's next for Incision?
With this major enterprise-level funding, Incision is expected to prioritize the international expansion of its digital ecosystem and the further integration of its platforms into hospital workflows. The strategic roadmap likely includes the development of new modules for Incision Academy and the enhancement of Incision Assist to support more complex surgical specialties. As the company scales, the focus will remain on driving measurable improvements in patient outcomes and operational efficiency. By deepening its footprint in the global healthcare market, Incision aims to solidify its role as an essential partner for institutions seeking to modernize their perioperative care standards and empower frontline medical professionals with the latest evidence-based training.
See full Incision company page
